Bod Australia reports strong sales growth in H2 2020 by Martin Lane January 8, 2021January 8, 2021 Bod Australia has announced strong sales growth in the second half of 2020, filling 3,941 prescriptions […]
Industry reacts to TGA down-scheduling decision with cautious optimism by Martin Lane December 17, 2020December 17, 2020
Bod Australia sees 106% increase in monthly MediCabilis prescriptions by Emma Castle November 18, 2020November 18, 2020
Bod Australia furthers European expansion, with plans for US market underway by Martin Lane October 20, 2020October 20, 2020
Bod Australia launches observational study to collect patient data by Emma Castle September 29, 2020April 22, 2024
Bod achieves ‘Generally Recognised as Safe’ status in the US by Emma Castle September 23, 2020April 22, 2024
Warning over CBD ‘red herring’ amid concerns about TGA demands by Steve Jones July 15, 2020August 5, 2020
Bod Australia reports rise in prescriptions amid first UK sales by Steve Jones May 21, 2020April 9, 2024